"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Descriptor ID |
D016896
|
MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2002 | 0 | 2 | 2 |
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 2 | 2 |
2006 | 0 | 2 | 2 |
2007 | 0 | 1 | 1 |
2008 | 0 | 2 | 2 |
2009 | 0 | 1 | 1 |
2010 | 0 | 5 | 5 |
2011 | 0 | 8 | 8 |
2012 | 0 | 5 | 5 |
2013 | 0 | 8 | 8 |
2014 | 0 | 8 | 8 |
2015 | 0 | 7 | 7 |
2016 | 0 | 7 | 7 |
2017 | 0 | 5 | 5 |
2018 | 0 | 10 | 10 |
2019 | 0 | 6 | 6 |
2020 | 0 | 6 | 6 |
2021 | 0 | 14 | 14 |
2022 | 0 | 2 | 2 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Determining Breast Implant Prevalence: A Population Study of Italian Chest Radiographs. Aesthetic Plast Surg. 2023 06; 47(3):957-965.
-
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041). Eur J Cancer. 2023 05; 184:1-9.
-
Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children. Leukemia. 2022 12; 36(12):2769-2783.
-
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group. Haematologica. 2022 05 01; 107(5):1026-1033.
-
Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes: Results of a Randomized Controlled Trial (ECCE HOMO Study). Psychother Psychosom. 2022; 91(2):107-122.
-
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report. Front Immunol. 2021; 12:727814.
-
DCIS in Male and Aged Women with Comorbidities. Chirurgia (Bucur). 2021 12; 116(5 Suppl):S120-S127.
-
A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection. Cells. 2021 11 19; 10(11).
-
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells. Front Immunol. 2021; 12:782448.
-
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders. Sci Rep. 2021 09 08; 11(1):17823.